StockWatch
·
STALLION · Q2 FY27 · PREVIEW

Can Stallion sustain Q1's margin burst as helium facility ramps?

Strong Q1 earnings beat on volume growth and operational leverage set a high bar. Q2 will test whether the newly commissioned Semiconductor Gas facility can maintain momentum into the seasonally softer half, and whether margins hold near record highs.

Q2 FY27 resultsSTALLIONStallion India Fluorochemicals Ltd13 Nov 2026 · 3 min read

The bar: Q1 set a high one

Stallion India Fluorochemicals posted a blowout Q1 FY27: standalone revenue climbed 9.9% YoY and 10.4% QoQ to ₹121.45 Cr, while net profit surged 79% YoY to ₹18.57 Cr, with EBITDA margins expanding sharply. The company signalled strong operating leverage from its core specialty chemicals (refrigerants, fluorine-based intermediates) alongside early contributions from recently commissioned capacity (the 10,000 MTPA R-32 facility came online by August). For Q2, investors will watch whether this momentum persists and whether the newly commissioned Semiconductor & Specialty Gas facility (Khalapur, commenced September 2026) begins to add material revenue.

Revenue (standalone expected)

~₹120–128 Cr

On-plan growth trajectory: +7–11% YoY (mid-range ₹124 Cr), +1–5% QoQ. Semiconductor Gas facility began ops in Sep; contribution likely marginal in Q2 as startup ramp takes time.

PAT margin (expected)

~14–15%

Q1 delivered 15.2% (₹18.57 Cr PAT on ₹121.45 Cr revenue) — a 150bps expansion. Normalization to 14–15% is on-plan; margins may face minor seasonal/input headwinds in Q2.

EBITDA (expected)

~₹20–23 Cr

Estimate based on 16–18% EBITDA margin (typical post-expansion), supporting prior guidance on operating leverage.

What on-plan vs weak looks like

On-plan: Revenue ₹122–126 Cr (7–10% YoY growth), PAT ₹17–19 Cr (14–15% margin). This marks solid sequential momentum with the foundry base holding and helium facility adding low single-digit ₹ Cr revenue in its first full operational quarter. EBITDA margin stable ~16–17%. The company maintains its FY28 guidance (>₹1,100 Cr revenue, 15% PAT margin) without commentary shifts. Weak: Revenue misses ₹120 Cr (growth <7% YoY) or PAT drops below ₹16 Cr (margin <13%). This could signal helium facility delays, softness in refrigerant/fluoro-intermediate demand, or margin pressure from raw material costs. Input inflation (HF, chlorine, energy) is a watch point in specialty chemicals, and any supply-chain disruption to the new facility would be flagged.

On track for FY27–28 guidance?

The company guided for FY28 revenue >₹1,100 Cr with a 15% PAT margin. At the current run-rate — Q1 at ~₹490 Cr annualized revenue, and assuming Q2–Q4 average ~₹120 Cr/quarter — FY27 revenue could land ~₹460–480 Cr (roughly in line with a prior-year base for a 10–12% ramp year). The new Semiconductor Gas facility should materially pull FY28 into the >₹1,100 Cr zone if ramp proceeds on schedule (full capacity contribution expected in H2 FY27–H1 FY28). Q2 will be the first test of this facility in a full operating quarter. Any slippage in ramp or demand would jeopardise the FY28 target.

Since last quarter: the filings scan

Semiconductor Gas facility live (Sep 19): Commercial operations commenced at the Khalapur debulking and blending plant — a strategic move into high-margin specialty gases (high-purity helium, neon, argon for semiconductor/electronics). The facility is designed for 1,200 MT annual capacity; contribution in Q2 will be early-stage ramp. GST inspection closed (Oct 15): Maharashtra State GST authorities completed their inspection and search at the registered office. The company cooperated and settled tax liability. Routine compliance closure — no material regulatory overhang flagged. Trading window closed (Sep 28): Compliance-driven closure ahead of result announcement. No insider-trading red flags reported in the block-deal data (Junomoneta bulk trades in July were buy/sell pairs at ₹205 — routine liquidity flow). Promoter stake steady: Shareholding: FII 0.83%, DII 1.53%, Promoter 47.80% (Q1 FY27). No major stock pledge or dilution signals in recent filings.

Three things to watch on result day
  • 1 · Semiconductor Gas revenue & margin

    How much did the helium/specialty gas facility contribute in its first full quarter? Look for commentary on utilization rates, pricing, and when management expects full-capacity contribution. This will calibrate FY28 growth.

  • 2 · Core refrigerant/fluoro demand trajectory

    Stripped of the helium facility, is the base business (R-32, HFC-410A, fluorine intermediates) holding growth? Demand signals here indicate whether the 7–11% YoY growth is sustainable or facing seasonal/cyclical headwinds.

  • 3 · Input costs & margin guidance

    Q1 saw 150bps margin expansion — unprecedented. Is this a durable uplift (pricing power, mix shift, scale) or a one-time beat that normalizes? Input inflation (HF, energy) is a risk in specialty chemicals. Listen for commentary on cost trajectory and revised FY27–28 margin guidance.

Stallion India Fluorochemicals faces a credibility test in Q2: can it sustain Q1's margin fireworks and demonstrate that the new Semiconductor Gas facility is a real growth driver, not a one-time capacity sink? Revenue is likely on-plan at ₹120–128 Cr (7–11% YoY growth), but the margin story — whether it holds near Q1's 15.2% or normalizes lower — will determine whether the market retains confidence in the FY28 >₹1,100 Cr target.

The stock at ₹196.88 is down 45% from all-time highs but up 98% from 52-week lows, reflecting the volatility of specialty-chemical micro-caps. Catalyst clusters (facility ramp, margin trajectory, any M&A or capacity expansion announcements) are key to re-rating higher. Watch for early-ramp commentary and demand signals from the semiconductor gas side on Nov 13.

Informational and educational content only. Not investment advice.